Vir And GSK Boosted By COVID-19 Antibody Success, Prepare EUA Filing
Single Antibody Cuts Risk Of Death, Hospitalization
The companies look set to join Lilly and Regeneron once an EUA is secured, but producing enough supplies to meet demand will be the next challenge.